Article thumbnail

Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study

By Thomas Strowitzki, Waldemar Kuczynski, Arnd Mueller and Peter Bias
Publisher: Springer Nature
Year: 2016
DOI identifier: 10.1186/s12958-016-0164-y
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://rbej.biomedcentral.com... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.